2026 Chicago Hematology and Oncology Conference
Accreditation: 10.75 Nursing Contact Hours | 10.75 ABIM MOC II | 10.75 AMA PRA Category 1 Credit™ | 10.75 ACPE Pharmacy
Venue: Hilton Orrington/Evanston, 1710 Orrington Avenue, Evanston, IL, United States
Official conference page for 2026 Chicago Hematology and Oncology Conference. https://binaytara.org/projects/conferences/2026-chicago-hematology-and-oncology-conference
Faculty disclosures
Identification and mitigation of potential conflicts of interest
All conflict of interest has been identified and mitigated for individuals in control of contents.
Planning committee disclosure statement
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Session Chair
Awaiting faculty disclosure.
Topic Presenters
has a financial relationship (Consultant) with Adaptimmune; financial relationship (Consultant) with Attivare; financial relationship (Consultant) with Bayer; financial relationship (Consultant) with Boehringer Ingelheim; financial relationship (Consultant) with Daiichi-Sankyo; financial relationship (Speaker) with Deciphera; financial relationship (Consultant) with Deciphera; financial relationship (Consultant) with EMD serono; financial relationship (Consultant) with Ipsen; financial relationship (Grant Or Contract) with Obsidian; financial relationship (Consultant) with Rain Therapeutics; financial relationship (Consultant) with Replimmune; financial relationship (Consultant) with Springworks; financial relationship (Speaker) with Springworks.
has a financial relationship (Other) with Artios; financial relationship (Other) with Astellas; financial relationship (Other) with AstraZeneca; financial relationship (Other) with Blueprint; financial relationship (Other) with Compugen; financial relationship (Other) with Duality Bio; financial relationship (Other) with Iovance; financial relationship (Other) with K Group beta; financial relationship (Other) with PHEAST; financial relationship (Other) with PI for an industry sponsored trial: Roche; financial relationship (Other) with Pfizer; financial relationship (Other) with Sanofi; financial relationship (Other) with Sermonix; financial relationship (Other) with Sustimmune.
No, I have not had a financial relationship with an ineligible company within the past 24 months.
has a financial relationship (Consultant) with Astra Zeneca, Lilly, DSI, Tersera, Genentech, Pfizer.
Awaiting faculty disclosure.
Awaiting faculty disclosure.
has a financial relationship (Consultant) with Amgen; financial relationship (Consultant) with Astellas; financial relationship (Consultant) with Cycle; financial relationship (Consultant) with Geron; financial relationship (Researcher) with Incyte; financial relationship (Consultant) with Jazz; financial relationship (Consultant) with Karyopharm; financial relationship (Consultant) with Novartis; financial relationship (Researcher) with Pfizer; financial relationship (Consultant) with Refined Oncology; financial relationship (Researcher) with Servier; financial relationship (Consultant) with Sobi; financial relationship (Researcher) with Stemline; financial relationship (Researcher) with Sumitomo; financial relationship (Consultant) with Syndax; financial relationship (Other) with Takeda.